Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 896 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Reckitt Benckiser chooses Cegedim solutions

Reckitt Benckiser will also implement Cegedim Relationship Management’s integrated suite of Support Services, including Helpdesk and Asset Management. According to Reckitt Benckiser, the Mobile Intelligence for iPad would

Silence, miRagen to evaluate DBTC delivery system

As per the agreement, miRagen will provide Silence with specific miRNA sequences, which Silence will formulate with its proprietary DBTC delivery system to develop multiple candidate drugs. MiRagen

Shire, ICON sign new strategic partnership

ICON will provide Shire with a range of services including site and country feasibility, ethics and regulatory submissions, clinical trial monitoring, project management, medical management and medical data

Endo, BioDelivery ink BEMA Buprenorphine deal

BEMA Buprenorphine is a transmucosal form of buprenorphine, a partial mu-opiate receptor agonist, which incorporates a bioerodible mucoadhesive (BEMA) technology. BEMA Buprenorphine is currently in phase III trials

South Korea approves Anti-leukemia drug production

According to Korea Food and Drug Administration (KFDA), Supect, a drug manufactured by Ilyang Pharmaceutical has been approved to treat leukemia in those resistant to currently available anti-leukemia

Strides Arcolab to sell Australian unit

Strides Arcolab is also securing investment bank Jefferies’ advice on divestment of softgel and anti-retro viral (ARV) drug manufacturing, timesofindia.indiatimes.com reported. Strides Arcolab plans to lay more emphasis